Home/Filings/4/0001493152-24-015789
4//SEC Filing

GIRGENTI STEVEN 4

Accession 0001493152-24-015789

CIK 0001712762other

Filed

Apr 23, 8:00 PM ET

Accepted

Apr 24, 4:00 PM ET

Size

9.7 KB

Accession

0001493152-24-015789

Insider Transaction Report

Form 4
Period: 2024-04-03
GIRGENTI STEVEN
DirectorExecutive Chairman
Transactions
  • Tax Payment

    Common Stock

    2024-04-03$2.24/sh33,438$74,9011,023,168 total
  • Exercise/Conversion

    Common Stock

    2024-04-03$1.16/sh+64,848$75,2241,056,606 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-04-0364,8480 total
    Exercise: $1.16Exp: 2024-04-28Common Stock (64,848 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    8,955
Footnotes (3)
  • [F1]Represents shares withheld to cover the exercise price of the options exercised.
  • [F2]These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F3]This option vested in 7 equal monthly installments beginning on April 28, 2014.

Documents

1 file

Issuer

bioAffinity Technologies, Inc.

CIK 0001712762

Entity typeother

Related Parties

1
  • filerCIK 0001055530

Filing Metadata

Form type
4
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:00 PM ET
Size
9.7 KB